Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Neovasc Inc (NQ: NVCN )

29.88 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 24, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 29.88
Bid (Size) 29.41 (1)
Ask (Size) 30.00 (7)
Prev. Close 29.88
Today's Range 29.88 - 29.88
52wk Range 4.585 - 29.89
Shares Outstanding 67,654,729
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Neovasc Inc. (NASDAQ: NVCN) is a Stock Spotlight on 3/17
Via Investor Brand Network
Neovasc Shareholders Approve Acquisition by Shockwave Medical
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire

Performance

YTD
+88.99%
+88.99%
1 Month
+4.11%
+4.11%
3 Month
+89.83%
+89.83%
6 Month
+359.69%
+359.69%
1 Year
+179.25%
+179.25%

More News

Read More
A Bull Market Is Coming: 1 Outstanding Growth Stock Down 36% to Buy and Hold
Via The Motley Fool
Neovasc Announces German Reimbursement Renewal
Via NewMediaWire
Mergers and Acquisitions in 2023 Off To A Strong Start
Via MarketBeat
Exposures Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2023
Via Benzinga
Neovasc (NASDAQ: NVCN) (TSX: NVCN) Enters into Agreement to be Acquired by Shockwave Medical (NASDAQ: SWAV) for $100 Million & CVR
Via Spotlight Growth
Exposures Product Safety
Nasdaq Edges Higher; Neovasc Shares Jump
Via Benzinga
Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Why Neovasc Shares Are Trading Higher Today
Via Benzinga
Dow Dinged As Big Bank Earnings Weigh
Via Talk Markets
Dow Tumbles 300 Points; Morgan Stanley Beats Q4 Views
Via Benzinga
Dow Drops Over 150 Points; Goldman Sachs Profit Misses Expectations
Via Benzinga
Shockwave Medical Seeks To Bolster Its Cardiovascular Disease Portfolio With Neovasc Acquisition
Via Benzinga
Shockwave Medical to Acquire Neovasc
Via NewMediaWire
Exposures Product Safety
Shockwave Medical Announces Agreement to Acquire Neovasc
From Shockwave Medical, Inc.
Via Globe NewsWire
Neovasc Announces Progress on COSIRA-II Clinical Trial
Via NewMediaWire
Neovasc Comments on European Heart Journal Publication
Via NewMediaWire
Topics Intellectual Property
Exposures Intellectual Property
Neovasc Announces Third Quarter Financial Results and Provides Corporate Update
Via NewMediaWire
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Neovasc Reducer Obtains U.S. Outpatient Reimbursement
Via NewMediaWire
Neovasc to Report Third Quarter Financial Results on November 10, 2022
Via NewMediaWire
Neovasc Provides Corporate Update Following Clinical Data Release
Via NewMediaWire
Neovasc to Participate in LSI Europe 2022 Emerging MedTech Summit
Via NewMediaWire
Neovasc Comments on New ICD-10-CM Diagnosis Codes for Refractory Angina
Via NewMediaWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.